Article Type
Changed
Tue, 05/03/2022 - 16:09
Display Headline
Post-PCI Fluvastatin for Diabetics

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 22(6)
Publications
Topics
Page Number
32
Legacy Keywords
fluvastatin, diabetes, Lescol Intervention Prevention Study, LIPS, long-term statin therapy, percutaneous coronary intervention, PCI, cardiac risksfluvastatin, diabetes, Lescol Intervention Prevention Study, LIPS, long-term statin therapy, percutaneous coronary intervention, PCI, cardiac risks
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 22(6)
Issue
Federal Practitioner - 22(6)
Page Number
32
Page Number
32
Publications
Publications
Topics
Article Type
Display Headline
Post-PCI Fluvastatin for Diabetics
Display Headline
Post-PCI Fluvastatin for Diabetics
Legacy Keywords
fluvastatin, diabetes, Lescol Intervention Prevention Study, LIPS, long-term statin therapy, percutaneous coronary intervention, PCI, cardiac risksfluvastatin, diabetes, Lescol Intervention Prevention Study, LIPS, long-term statin therapy, percutaneous coronary intervention, PCI, cardiac risks
Legacy Keywords
fluvastatin, diabetes, Lescol Intervention Prevention Study, LIPS, long-term statin therapy, percutaneous coronary intervention, PCI, cardiac risksfluvastatin, diabetes, Lescol Intervention Prevention Study, LIPS, long-term statin therapy, percutaneous coronary intervention, PCI, cardiac risks
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media